Latest Regulatory News

Gold Road Resources has entered a definitive agreement for acquisition by Gold Fields Limited, offering shareholders a compelling 43% premium and a special dividend. The scheme awaits shareholder and court approval, targeting completion by October 2025.

OD6 Metals has secured regulatory approval to resume exploration at its historic Gulf Creek Copper Project in NSW, with assay results from six completed drill holes expected soon to shape future programs.

Rox Resources has raised A$40 million through a strongly supported institutional placement to accelerate early development works at its high-grade Youanmi Gold Project, significantly de-risking the pathway to production.

Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.

Barton Gold Holdings has released an Optimised Scoping Study for its Tunkillia Gold Project, revealing significant improvements in project economics, including a sub-one-year payback and reduced capital expenditure. The study paves the way for accelerated feasibility work and funding efforts.

Reliance Worldwide Corporation updates on the financial impact of new US tariffs, outlining a multi-pronged mitigation strategy and revising its FY25 sales outlook amid market uncertainty.

Lotus Resources has received critical regulatory approval from Malawi’s Atomic Energy Regulatory Authority to resume uranium mining at its Kayelekera project, paving the way for production restart in the third quarter of 2025.

Somerset Minerals has completed its acquisition of the high-grade Coppermine copper project in Nunavut, Canada, and is set to begin a maiden exploration campaign backed by a $2.39 million capital raise.

Finder Energy has advanced its Kuda Tasi and Jahal oilfields development by completing a comprehensive subsea concept study, delivering refined cost estimates and development scenarios that strengthen project economics and de-risking efforts.

Immutep’s combination of eftilagimod alfa (efti) and KEYTRUDA® delivers a striking 17.6-month median overall survival in head and neck cancer patients with low PD-L1 expression, a group with limited treatment options.

MetalsGrove Mining Limited has completed the acquisition of three gold joint venture permits covering 950 km² in central-west Côte d’Ivoire, positioning itself near the prolific Abujar gold mine. The company plans to initiate exploration soon, leveraging promising geological indicators and regional activity.

Westpac Banking Corporation posted a $3.5 billion net profit for the first half of 2025, maintaining strong capital ratios and advancing its digital transformation and sustainability initiatives despite a slight earnings dip.